You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 16, 2025

Details for Patent: 6,150,337


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,150,337
Title: Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
Abstract:Ribavirin is employed in a manner which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin is used to suppress Type 2-mediated T cell responses and promote Type 1-mediated T cell response. Thus, instead of administering Ribavirin in its well-recognized role as an anti-viral agent, Ribavirin is herein used in the treatment of imbalances in lymphokine expression. Such imbalances may be found to be concomitants of allergic atopic disorders such as allergic asthma and atopic dermatitis, helminth infection and leishmaniasis, and various primary and secondary immunodeficiencies, which may or may not also be associated with viral infection.
Inventor(s): Tam; Robert (Costa Mesa, CA)
Assignee: ICN Pharmaceuticals, Inc. (Costa Mesa, CA)
Application Number:09/156,646
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,150,337

Introduction

United States Patent 6,150,337, hereafter referred to as the '337 patent, is a significant patent that has contributed to the intellectual property landscape in its respective field. To understand its impact and the nuances of its claims, it is essential to delve into the details of the patent itself, as well as the broader context of patent law and practices.

Background of the Patent

The '337 patent, like many others, is part of a larger family of patents that may include continuations, continuations-in-part, and other related patents. Understanding the family tree of patents can provide insights into the evolution of the technology and the strategic filing of patent applications.

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of protection granted to the inventor. The '337 patent would typically include a set of independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations to the independent claims[3].

Claim Types

  • Independent Claims: These claims define the invention in its broadest terms and are crucial for determining the patent's scope.
  • Dependent Claims: These claims build upon the independent claims by adding specific details or limitations, often to cover various aspects or embodiments of the invention.

Claim Interpretation

The interpretation of patent claims is a critical aspect of patent law. Courts often use the "plain and ordinary meaning" of the claim terms, as well as the specification and prosecution history of the patent, to determine the scope of the claims. This is evident in cases like Contour IP Holding LLC v. GoPro, Inc., where claim construction is a pivotal issue[5].

Patent Scope and Coverage

Technical Field

The '337 patent would be classified within a specific technical field, which could range from software and electronics to mechanical or pharmaceutical inventions. Understanding the technical field helps in identifying the relevant prior art and the innovative contributions of the patent.

Novelty and Non-Obviousness

For a patent to be valid, its claims must meet the criteria of novelty and non-obviousness. This involves comparing the claimed invention against the prior art to ensure it is new and not an obvious extension of existing knowledge[5].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents the same inventor from obtaining multiple patents for the same invention or for obvious variations of the same invention. This is particularly relevant when dealing with patent families, as seen in the case of In re Cellect LLC, where multiple related patents were analyzed for ODP[1].

Patent Term and Adjustments

The '337 patent, like other patents, has a limited term, typically 20 years from the earliest filing date. However, Patent Term Adjustments (PTA) can extend this term if there are delays during the prosecution process. This is an important consideration, especially in cases where multiple related patents are involved and their expiration dates need to be aligned[1].

Economic and Legal Implications

Patent Litigation

Patents like the '337 patent can be involved in litigation, where the validity and infringement of the claims are contested. The outcome of such litigation can significantly impact the patent landscape, as seen in cases like *Contour IP Holding LLC v. GoPro, Inc.[5].

Licensing and Monetization

The '337 patent could be a valuable asset for licensing or monetization. Companies often license patents to generate revenue or to gain access to complementary technologies.

Small Claims Patent Court

The concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could potentially impact how disputes related to patents like the '337 patent are resolved. Such a court would aim to provide a more streamlined and cost-effective process for resolving patent disputes, especially for smaller entities[2].

Data and Research

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including those granted between 1976 and 2014. This dataset can be used to analyze trends and patterns in patent claims, which could be relevant for understanding the broader context of the '337 patent[3].

Geographic and Sectoral Analysis

Data from sources like the National Science Foundation (NSF) can provide insights into the geographic distribution and sectoral breakdown of patenting activity. This can help in understanding the broader innovation landscape and how the '337 patent fits into it[4].

Key Takeaways

  • Claims Analysis: Understanding the structure and interpretation of patent claims is crucial for determining the scope of protection.
  • Patent Scope and Coverage: The technical field, novelty, and non-obviousness of the invention are key factors in defining the patent's scope.
  • ODP and Patent Term: Ensuring compliance with ODP and understanding patent term adjustments are vital for maintaining the validity of related patents.
  • Economic and Legal Implications: Patents can be significant in litigation, licensing, and monetization, and their impact can be influenced by legal and economic factors.
  • Data and Research: Utilizing datasets and research can provide valuable insights into the broader patent landscape.

FAQs

Q: What is the significance of independent and dependent claims in a patent? A: Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding specific limitations.

Q: How does the doctrine of Obviousness-Type Double Patenting (ODP) affect patent families? A: ODP prevents the same inventor from obtaining multiple patents for the same invention or obvious variations, ensuring that each patent in a family does not overlap in an invalidating manner.

Q: What is the role of Patent Term Adjustments (PTA) in extending the term of a patent? A: PTA extends the term of a patent if there are delays during the prosecution process, ensuring that the patent holder does not lose time due to USPTO delays.

Q: How can the concept of a small claims patent court impact patent disputes? A: A small claims patent court could provide a more streamlined and cost-effective process for resolving patent disputes, particularly beneficial for smaller entities.

Q: What kind of data can be used to analyze trends and patterns in patent claims? A: The USPTO's Patent Claims Research Dataset and other datasets from organizations like the NSF can be used to analyze trends and patterns in patent claims and broader patenting activity.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,150,337

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,150,337

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 016597 ⤷  Try for Free
Austria 216886 ⤷  Try for Free
Austria 271063 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.